3.28
CytoMed Therapeutics Ltd
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions SGD
FY21:
FY22:
2.49
FY23:
10.1
FY24:
6.00
FY25:
3.66
(positive)
Change from FY21 to FY25
millions SGD
FY21:
2.80
FY22:
2.73
FY23:
2.27
FY24:
4.07
FY25:
4.32
Total assets
Change from FY21 to FY25
millions SGD
FY21:
6.08
FY22:
5.23
FY23:
12.4
FY24:
10.1
FY25:
7.98
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions SGD
FY21:
2.94
FY22:
4.17
FY23:
0.72
FY24:
0.61
FY25:
0.71
(negative)
Change from FY21 to FY25
millions SGD
FY21:
0.55
FY22:
0.48
FY23:
0.41
FY24:
0.42
FY25:
0.42
(positive)
Change from FY21 to FY25
millions SGD
FY21:
2.59
FY22:
0.59
FY23:
11.2
FY24:
9.04
FY25:
6.85
Total liabilities & equity
Change from FY21 to FY25
millions SGD
FY21:
6.08
FY22:
5.23
FY23:
12.4
FY24:
10.1
FY25:
7.98
All amounts in millions SGD